BlackBerry Ltd (NASDAQ:BBRY)’s plans to unveil a square-screened smartphone are further emphasizing Chief Executive Officer John Chen’s shift away from the consumer market toward business and professional users. BlackBerry Ltd (NASDAQ:BBRY) belongs to Technology sector. Its net profit margin is -6.73% and weekly performance is -4.52%. On last trading day company shares ended up $10.56. BlackBerry Ltd (NASDAQ:BBRY) distance from 50-day simple moving average (SMA50) is 4.59%.

Transocean LTD (NYSE:RIG) had its price target lowered by Credit Suisse to $30.00 in a research note issued to investors on Tuesday. Transocean Ltd. (NYSE:RIG) shares decreased -0.59% in last trading session and ended the day at $33.43. RIG Gross Margin is 42.40% and its return on assets is 5.60%. Transocean Ltd. (NYSE:RIG) quarterly performance is -23.80%.

Wausau Paper Corp. (NYSE:WPP) Director Londa J. Dewey acquired 4,000 shares of Wausau Paper Corp. stock on the open market in a transaction that occurred on Monday, August 18th. The stock was purchased at an average price of $8.89 per share, for a total transaction of $35,560.00. Following the completion of the purchase, the director now directly owns 9,000 shares of the company’s stock, valued at approximately $80,010. On 23 September, Wausau Paper Corp. (NYSE:WPP) shares decreased -0.95% and was closed at $8.30. WPP EPS growth in last 5 year was -12.20%. Wausau Paper Corp. (NYSE:WPP) year to date (YTD) performance is -34.23%.

Atossa Genetics Inc. (NASDAQ: ATOS) announced that the U.S. Food and Drug Administration has issued a determination that the ForeCYTE Breast Aspirator is “not substantially equivalent” to its predicate device. The ForeCYTE Breast Aspirator is, therefore, not cleared by the FDA for marketing in the United States. Atossa plans to now commercialize in the U.S. an alternative breast aspirator, called the FullCYTE Breast Aspirator. The FullCYTE Breast Aspirator is an FDA-cleared device that was acquired by Atossa in 2012 and is a subset of Atossa’s FullCYTE Microcather which Atossa has been preparing for commercialization over the past 12 months. Atossa will now prioritize the commercial launch of the FullCYTE Breast Aspirator in the U.S. market. Atossa Genetics, Inc. (NASDAQ:ATOS) ended the last trading day at $2.33. Company weekly volatility is calculated as 8.29% and price to cash ratio as 4.00. Atossa Genetics, Inc. (NASDAQ:ATOS) showed a weekly performance of 8.88%.

On Sep 9, Walt Disney Co. (DIS), DreamWorks Animation SKG Inc. (NASDAQ:DWA) and other film industry companies were sued in an antitrust case that may reflect a new wave of litigation applying traditional price-fixing claims to labor markets. DreamWorks Animation SKG Inc. (NASDAQ:DWA) shares decreased -1.23% in last trading session and ended the day at $22.49. DWA Gross Margin is 23.70% and its return on assets is -1.40%. DreamWorks Animation SKG Inc. (NASDAQ:DWA) quarterly performance is -0.35%.